Dopamine Receptor Agonists: New Formulations and New Potentials in the Treatment of Parkinson’s Disease
Crossref DOI link: https://doi.org/10.1007/s11055-016-0339-1
Published Online: 2016-10-22
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Katunina, E. A.
Titova, N. V.
Bezdol’nyi, Yu. N.
Shikkerimov, R. K.
Gasanov, M. G.
Burd, S. G.
Lebedeva, A. V.
Boiko, A. N.
License valid from 2016-10-01